Charles Makin
Global Head, Real-World Evidence Strategy, Biogen (MA, USA)
In Makin’s current position, he oversees real-world evidence projects across all therapeutic areas for marketed and pipeline products.
Before joining Biogen, Makin served as the Vice President for ICON Plc.’s (Dublin, Ireland) Real-World Evidence Late Phase Research Unit, the world’s second largest research group dedicated to prospective data collection.
Prior to that, Makin held real-world evidence and health economics and outcomes research leadership positions at IQVIA (NC, USA), Optum (MN, USA), Anthem (IN, USA) and Humana (KY, USA).